4 August 2020 - Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone wanting to have their say about our annual tender process and a proposal to modify our contracting arrangements.
Every year PHARMAC invites tenders for the supply of certain medicines to DHB hospitals and/or to community pharmacies in New Zealand. This year, as part of the feedback we are seeking, we are considering a different approach to competitive procurement.
We currently award Sole Supply Status to community medicines, where we have only one brand listed in the Pharmaceutical Schedule for funding. In DHB hospitals we currently award Hospital Supply Status, which means the medicine becomes the primary brand that DHB hospitals buy, and the supplier is guaranteed a certain share of the market by volume.